Technical Bulletin. Cholesterol Reference Method Laboratory Network (CRMLN) Overview. TB Rev. 0

Similar documents
Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips

(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)

Why do we need SD LipidoCare?

1 PROTOCOL. Comparison Study Summary

Polymer Technology Systems, Inc. CardioChek PA Comparison Study

1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)

Agenda. 15 Dec

Customer Bulletin. Questions/Comments? Please call Customer Service at (Direct) or (Toll-free inside USA).

Guide to Fulfillment of Measurement Uncertainty

Self-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer

Patricia C. Fallest-Strobl, 1 Elin Olafsdottir, 2 Donald A. Wiebe, 1 and James O. Westgard 1 * Lipoproteins

The Second Report of the Expert Panel on Detection,

Calibration of High-Density Lipoprotein Cholesterol Values From the Korea National Health and Nutrition Examination Survey Data, 2008 to 2015

Electrolyte Analyzer with Ion-Selective Electrode and Blood Gas analyzer

ARTICLE. Utility of Direct Measurement of Low-Density Lipoprotein Cholesterol in Dyslipidemic Pediatric Patients

For In Vitro Diagnostic Use. Rx Only. Reviewed by Date Reviewed by Date

General Chemistry Scheme Guide

Review. Standardization of Measurements for Cholesterol, Triglycerides, and Major Lipoproteins

Performance Guide. icheck Iodine The test kit to measure iodine in salt

All-in-One Portable Lipid Analyzer

1. PROTOCOL. Comparison Study Summary. Tuality Healthcare 324 SE 9 th Ave. Suite E Hillsboro, OR July 30, 2014

The analytical phase

1 Introduction Imprecision Within-run imprecision, results Day-to-day imprecision, results... 2

Alere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC

Metabolic Monitoring Point of Care Testing

Aina Blood Monitoring System

Method Comparison Report Semi-Annual 1/5/2018

CDC s Clinical Standardization Programs

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Accuracy of Three Dry-Chemistry Methods for Lipid Profiling and Risk Factor Classification

Commutability studies undertaken by the LNE : the case of lipid and lipoprotein testing. Vincent Delatour, PhD

Reference Material Institute for Clinical Chemistry Standards (ReCCS)

Preparing for the road ahead. LEARN MORE ABOUT these 5 risks

Individual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab

Customer Bulletin January 2017

Evaluation of Lipid Profile In Liver Cancer

Performance Guide. icheck Chroma 3 The test kit to measure vitamin A in oil

Engaging patients and providers with the right information, at the right time, to do the right thing

SCIEX Vitamin D 200M Assay for the Topaz System

EVALUATING THE UNCERTAINTY OF MEASUREMENT ON BLOOD'S GLUCOSE LEVEL

6to. Congreso Virtual de Cardiología - 6th Virtual Congress of Cardiology

Evaluation of Calculated Low-Density Lipoprotein Against a Direct Assay

MOLINA HEALTHCARE OF CALIFORNIA

METHOD VALIDATION: WHY, HOW AND WHEN?

INTERNAL QUALITY CONTROL ( Q I C) QC)

Know Your Numbers Your Most Vital Statistic

Piccolo Lipid Panel Reagent Disc

Lipid Profiles. Important: Read over the section on correlation coefficients in the Guidelines for Statistics and Graphs in General Education Biology.

Lipoprotein Particle Profile

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice

INSTRUCTIONS FOR USE

Suppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS

Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC

1. Reagent Store at 2-8 ºC.

Lipid Profile Analysis of Aircrew

LDL . (LDL) Downloaded from ijdld.tums.ac.ir at 12:38 IRST on Friday February 1st 2019 LDL LDL NCEP-ATP-III (LDL) :

This package insert contains information to run the Cholesterol assay on the ARCHITECT c Systems.

Evaluation of a Rapid Homogeneous Method for Direct Measurement of High-Density Lipoprotein Cholesterol

Traceable lipoprotein counting for Cardiovascular disease risk assessment Vincent DELATOUR, PhD

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Comparison of Friedewald Formula and Modified Friedewald Formula with Direct Homogeneous Assay for Low Density Lipoprotein Cholesterol Estimation

In Vitro Diagnostic Glucose Test System

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

METHOD VALIDATION CASE

Supplementary Online Content

HDL CHOLESTEROL. 01 English - Ref.: 13. Ref.:13. Insert

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

Author's response to reviews

Is Universal Pediatric Lipid Screening Justified? YES. Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016

The Pharmacists Role in Lipid Management

Reducing low-density lipoprotein cholesterol treating to target and meeting new European goals

Comparison of Different estimated Formulas with Direct Estimation of Low-density Lipoprotein Cholesterol

ISO INTERNATIONAL STANDARD

White Paper, Evaluation of WaveSense JAZZ Blood Glucose Monitoring System Analytical Performance to EN ISO 15197:2015 Standard

Perspectives on Large Simple Trials

Laboratory Medicine Standardization Activity in Japan

Challenges in Performing a Scientifically Meaningful Lipemic Plasma Test in Bioanalytical Method Validation

How would you manage Ms. Gold

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Mike Hinds, Royal Canadian Mint

LDL LD. 01 English - Ref.: 129. Ref.:129. Insert. Intended use. Methodology. Reagents. Test principle. Summary. Precautions and warnings

Serum low-density lipoprotein and high-density lipoprotein cholesterol. determined by ultracentrifugation and high-performance liquid

Cholesterol (blood, plasma, serum)

GlucoMen LX PLUS blood glucose and blood ketone meter. Accuracy Evaluation to New ISO 15197:2013, with Technical and Specification Data

AP Statistics Practice Test Unit Seven Sampling Distributions. Name Period Date

Current Challenges in CardioMetabolic Testing. Kenneth French, Director of Clinical Operations

Basic Biostatistics. Dr. Kiran Chaudhary Dr. Mina Chandra

USING THE ACCESS AMH ASSAY IN YOUR LABORATORY

Section Editor Mason W Freeman, MD

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Test Definition: FNMR2 NMR LipoProfile w/ir Markers

Case # 278 Should lipoprotein cholesterol assays disappear?

3 Linearity and Detection Limit Linearity Detection limit... 4

Week 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including

Lipid Management 2013 Statin Benefit Groups

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

Diabetes Care 31: , 2008

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

Transcription:

Technical Bulletin Reference Method Laboratory Network (CRMLN) Overview TB000020 Rev. 0

Reference Method Laboratory Network (CRMLN) - General Information With guidance from the US Centers for Disease Control and Prevention (CDC), headquartered in Atlanta, Georgia, USA, the CRMLN is a network of labs in the US and around the world that was established to certify manufacturers of clinical diagnostic products that measure Total (TC), HDL (HDL-C), or LDL (LDL-C). Certification provides evidence of traceability to the National Reference System for (NRS/Chol). The CRMLN also issues guidelines regarding the performance of products used to analyze blood samples for specific lipid levels. The CRMLN uses reference methods that are rigorously standardized to the CDC reference methods to ensure uniformity of lipid measurements worldwide. Certification Protocol for Manufacturers The National Education Program (NCEP) Adult Treatment Panel has recommended specific medical decision points for serum cholesterol to aid in the detection, evaluation, and treatment of people with elevated cholesterol levels. These medical decision points were derived from national population studies in which the cholesterol assays were standardized to the Abell-Kendall reference method at the Centers for Disease Control and Prevention (CDC), a major component of the National Reference System for (NRS/CHOL). The NCEP Laboratory Standardization Panel has urged that clinical laboratories standardize their assays to the NRS/CHOL accuracy base to properly classify patients according to the NCEP medical decision points. The panel agreed that standardization could be achieved most effectively through the manufacturers of analytical instruments and reagents. To facilitate standardization, CDC requested the Reference Method Laboratory Network (CRMLN) to provide access to the NRS/CHOL for both manufacturers and clinical laboratories. The CRMLN then developed a method comparison protocol leading to certification for analytical systems, reagent applications, calibrators, and reference materials. 2

Criteria for CRMLN cholesterol certification The CRMLN established test protocols use accepted gold standard reference methods. In order to be CRMLN certified, results must meet the following criteria: CRMLN cholesterol certification criteria Parameter Total HDL LDL R 2 >0.975 >0.975 >0.975 Bias at medical decision points 3% at 200 mg/dl (5.18 mmol/l) 3% at 240 mg/dl (6.22 mmol/l) 5% at 40 mg/dl (1.04 mmol/l) 5% at 60 mg/dl (1.55 mmol/l) 4% at 100 mg/dl (2.59 mmol/l) 4% at 130 mg/dl (3.37 mmol/l) 4% at 160 mg/dl (4.14 mmol/l) Average % bias 3% 5% 4% Among-run CV 3% 4% 4% NCEP guidelines for Total Error (TE) The National Education Program (NCEP) of the National Institutes of Health (NIH) has established test protocols and guidelines for acceptable deviation from truth (defined as the National Reference System for [NRS/Chol] reference value). These guidelines state that TE should be within the following limits from the reference value when these test protocols are followed: Total HDL LDL Total Error 8.9% 13% 12% 3

NCEP - Adult Treatment Panel (ATP) III guidelines for cholesterol management In addition to device certification guidelines, NCEP also publishes patient care guidelines and recommends a complete lipid profile for coronary heart disease risk assessment. Periodically NCEP updates its clinical guidelines for cholesterol testing and management. However, these current guidelines are not meant to replace the physician s clinical judgment; based on all the clinical and diagnostic information available, the physician must ultimately determine the appropriate treatment for each patient. ATP III classification of LDL, TC, and HDL 1 LDL Primary target of therapy US Units SI Units <100 mg/dl <2.59 mmol/l Optimal 100-129 mg/dl 2.59-3.35 mmol/l Near optimal/above optimal 130-159 mg/dl 3.36-4.12 mmol/l Borderline high 160-189 mg/dl 4.13-4.91 mmol/l High 190 mg/dl 4.92 mmol/l Very high Total <200 mg/dl <5.18 mmol/l Desirable 200-239 mg/dl 5.18-6.20 mmol/l Borderline high 240 mg/dl 6.21 mmol/l High HDL <40 mg/dl <1.04 mmol/l Low 60 mg/dl 1.55 mmol/l High 1. Executive summary of the Third Report of the National Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. 4

Why certify products for accuracy - what makes accuracy and precision so necessary? Accuracy and precision are extremely important in the field of science; without them there would be no way to determine if what is being measured is true. Accuracy refers to the degree of conformity of a measured or calculated quantity to an actual (true) value. Precision, on the other hand, is the degree to which repeat measurements or calculations yield the same or similar results. Accuracy is closely related to precision, but it s not the same thing. A result is said to be valid when it is both accurate and precise. Let s look at a common analogy to illustrate the difference between accuracy and precision. Figure 1. High accuracy with high precision When results have both a high degree of accuracy and precision they will be clustered together around the target area (true value). Figure 2. Low accuracy with high precision Results that are precise will be clustered together, but because they are inaccurate they will not be near the target area (true value). Figure 3. Low accuracy with low precision Results with both low precision and low accuracy will be scattered about, and may not be near each other or the target area. How is accuracy determined? A primary method for determining accuracy is to compare test results from one method to the values achieved from a method that is accepted as accurate, oftentimes referred to as the gold standard. 5

Variables that influence accuracy Bias, a function of accuracy, is used to describe how far results are from the true value, but bias does not tell the whole story. The precision of the results must also be considered. Precision is often discussed in terms of the standard deviation (SD) and the percent coefficient of variation (% CV). SD is a measure of how spread out the data points of a sample are. 1 SD = (x - x) 2 n 1 Statistics demonstrate that in normally distributed data sets, 68% of the results will fall in a range that is within 1 SD of the mean and 95% of the results will fall within 2 SD of the mean. -2 SD -1 SD mean +1 SD +2 SD 68% of the results 95% of the results The % CV is another measure of the variability of data that allows comparison of data across different data sets. The % CV is defined as SD as a percent of the average value. % CV = 1 SD x 100 Once the accuracy (bias) and precision (% CV) of an instrument have been calculated, one can determine a critical measurement known as the total error (TE). The calculation for TE is: TE = % Bias + 1.96 x % CV The TE is important in determining the acceptable range of systematic and random errors. The coefficient of determination (R 2 ) is a statistical measure of how well a model approximates real data points. In other words, R 2 shows what is generally referred to as the goodness of fit of a model. In cases with a single variable, such as this paper, it is the square of the correlation coefficient (r), which shows the tendency of two variables to move together. R 2 can range from 0 to 1; the closer to 1 the better the model fits the data. 6

References: 1. Executive Summary of the Third Report of the National Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. 2. National Reference System for, Reference Method Laboratory Network. (2004), Total Certification Protocol for Manufacturers - Revised - [Brochure]. Please contact your distributor for more information. 2012 Polymer Technology Systems, Inc. TB000020 Rev. 0 04/12 Polymer Technology Systems, Inc. 7736 Zionsville Road Indianapolis, IN 46268 USA +1-877-870-5610 (Toll-free inside US) +1-317-870-5610 (Direct) +1-317-870-5608 (Fax) www.cardiochek.com